|
|
| Research article summary (published 30 Mar 1996): |
Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.
Full Abstract
The very low density lipoprotein receptor (VLDL-r) is a cell-surface molecule specialized for the internalization of multiple diverse ligands, including apolipoprotein E (apoE)-containing lipoprotein particles, via clathrin-coated pits. Its structure is similar to the low-density lipoprotein receptor (LDL-r), although the two have substantially different systemic distributions and regulatory pathways. The present work examines the distribution of VLDL-r in the central nervous system (CNS) and in relation to senile plaques in Alzheimer disease (AD). VLDL-r is present on resting and activated microglia, particularly those associated with senile plaques (SPs). VLDL-r immunoreactivity is also found in cortical neurons. Two exons of VLDL-r mRNA are differentially spliced in the mature receptor mRNA. One set of splice forms gives rise to receptors containing (or lacking) an extracellular O-linked glycosylation domain near the transmembrane portion of the molecule. The other set of splice forms appears to be brain-specific, and is responsible for the presence or absence of one of the cysteine-rich repeat regions in the binding region of the molecule. Ratios of the receptor variants generated from these splice forms do not differ substantially across different cortical areas or in AD. We hypothesize that VLDL-r might contribute to metabolism of apoE and apoE/A beta complexes in the brain. Further characterizations of apoE receptors in Alzheimer brain may help lay the groundwork for understanding the role of apoE in the CNS and in the pathophysiology of AD.
Author information
Author/s: Christie, R H (RH); Chung, H (H); Rebeck, G W (GW); Strickland, D (D); Hyman, B T (BT);
Affiliation: Neurology Service, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Grants: AG08487 (Agency:NIA NIH HHS) ; AG12406 (Agency:NIA NIH HHS) ; GM42581 (Agency:NIGMS NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
Journal: Journal of neuropathology and experimental neurology (J Neuropathol Exp Neurol), published in UNITED STATES. (Language: eng)
Reference: 1996-Apr; vol 55 (issue 4) : pp 491-8
Dates: Created 1996/09/20; Completed 1996/09/20; Revised 2007/11/14;
PMID: 8786409, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Apolipoproteins E (0) ; Lipoproteins, LDL (0)Related articles
These are the most related articles currently in our database:
- Anatomic, metabolic, neuropsychological, and molecular genetic studies of three pairs of identical twins discordant for dementia of the Alzheimer's type.
30 Jan 1991 - Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls.
30 May 1990 - Neuronal bioenergetic defects, excitotoxicity and Alzheimer's disease: "use it and lose it".
29 Jun 1991 - Alzheimer's disease: the proteoglycans hypothesis.
30 Dec 1990 - Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes.
30 Aug 1991 - Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
30 Dec 1990 - [Physiologically active brain proteins as possible markers of mental diseases]
30 Dec 1991 - The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis.
29 Dec 1992 - In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer's disease.
30 Dec 1991 - N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study.
30 Jul 1992
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.